Sort
21,453 grants matching “tuberculosis”
Inhibitors of protein-protein interactions
$493,663Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Disrupting Biofilm Formation to Improve TB Drug Treatment
$493,620Randall J Basaraba · Colorado State University · R01 · FY2015 · AI
Discovery and Validation of Drug Targets in Vulnerable Populations
$493,607David Alland · Rbhs-New Jersey Medical School · R33 · FY2016 · AI
Rapid Diagnosis of XDR Tuberculosis
$493,460David Alland · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected Children
$493,453Anna M Mandalakas · Case Western Reserve University · R01 · FY2007 · AI
Resue of CF phagocyte function with CFTR modulator therapy
$493,389Benjamin T Kopp · Emory University · R01 · FY2024 · HL
Small molecule biomarkers for tuberculosis treatment, relapse, and cure
$493,237John T Belisle · Colorado State University · U18 · FY2010 · FD
Small molecule biomarkers for tuberculosis treatment, relapse, and cure
$493,237John T Belisle · Colorado State University · U18 · FY2011 · FD
The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
$493,227Judith Alissa Hahn · Boston Medical Center · P01 · FY2022 · AA
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$493,126Patrick S. Stayton · University Of Washington · R01 · FY2018 · AI
RESEARCH TRAINING CORE
$493,103Robert Anders · University Of Texas El Paso · P20 · FY2009 · MD
Understanding How the Ubiquitin Ligase CBL Regulates Innate Immune Responses
$493,094Bennett Penn · University Of California At Davis · R01 · FY2022 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$493,087Patrick S. Stayton · University Of Washington · R01 · FY2019 · AI
Pattern Recognition Receptors and Autophagy in Mtb Control in AIDS
$492,962Vojo P Deretic · University Of New Mexico Health Scis Ctr · R37 · FY2018 · AI
Genetics & Clinical Cohorts
$492,774Sarah Jane Dunstan · University Of Washington · U19 · FY2023 · AI
Human macrophage variation & TB pathogenesis
$492,747Thomas R Hawn · University Of Washington · U19 · FY2021 · AI
Regulation of Salmonella Virulence bythe PhoP Protein
$492,701Eduardo A. Groisman · Yale University · R01 · FY2018 · AI
Nanocarriers for transcutaneous delivery of vaccines
$492,665John D Clements · Tulane University Of Louisiana · R01 · FY2007 · EB
Broadly active inhibitors of high priority pathogens
$492,597Sequoia Pharmaceuticals, Inc. · R43 · FY2003 · AI
Molecular and Cellular Immunology
$492,495Jason G. Cyster · University Of California, San Francisco · T32 · FY2018 · AI
CD4 T Cells in Tuberculosis
$492,299Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AI
A novel Quadruple Knockout Mtb vaccine against tuberculosis
$492,258Subramanian Dhandayuthapani · Texas Tech University Health Sciences Center At El Paso · R15 · FY2021 · AI
Developing triazolopyrimidines as novel anti-tubercular agents
$492,250Tanya Parish · Seattle Children'S Hospital · R56 · FY2022 · AI
Diagnostic Tests and Immunotherapy of Sarcoidosis Using Mycobacterial Proteins
$492,000David R Moller · Johns Hopkins University · P50 · FY2012 · HL
Diagnostic Tests and Immunotherapy of Sarcoidosis Using Mycobacterial Proteins
$492,000David R Moller · Johns Hopkins University · P50 · FY2011 · HL